122 related articles for article (PubMed ID: 31303650)
21. Natural killer cell neoplasms.
Liang X; Graham DK
Cancer; 2008 Apr; 112(7):1425-36. PubMed ID: 18286525
[TBL] [Abstract][Full Text] [Related]
22. Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
Haji S; Shiratsuchi M; Matsushima T; Takamatsu A; Tsuda M; Tsukamoto Y; Tanaka E; Ohno H; Fujioka E; Ishikawa Y; Imadome KI; Ogawa Y
Int J Hematol; 2017 Apr; 105(4):540-544. PubMed ID: 27830541
[TBL] [Abstract][Full Text] [Related]
23. A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia.
Sun T; Pashaei S; Jaffrey I; Ryder J
Hum Pathol; 2003 May; 34(5):504-8. PubMed ID: 12792926
[TBL] [Abstract][Full Text] [Related]
24. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus (EBV)-induced CD30+ natural killer cell-type malignancy resembling malignant histiocytosis: malignant transformation in chronic active EBV infection associating hypogammaglobulinemia.
Tsutsumi Y; Tang X; Yamada T
Pathol Int; 1997 Jun; 47(6):384-92. PubMed ID: 9211526
[TBL] [Abstract][Full Text] [Related]
26. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
[TBL] [Abstract][Full Text] [Related]
27. Adult aggressive natural killer cell leukemia.
Zhang H; Meng Q; Yin W; Xu L; Lie L
Am J Med Sci; 2013 Jul; 346(1):56-63. PubMed ID: 23241562
[TBL] [Abstract][Full Text] [Related]
28. Lethal Epstein-Barr virus associated NK/T-cell lymphoma with primary manifestation in the conjunctiva.
Widmer S; Tinguely M; Egli F; Thiel MA
Klin Monbl Augenheilkd; 2005 Mar; 222(3):255-7. PubMed ID: 15785994
[TBL] [Abstract][Full Text] [Related]
29. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
30. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
31. Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia.
Kim BK; Hong KT; Kang HJ; An HY; Choi JY; Hong CR; Park KD; Lee DS; Shin HY
J Pediatr Hematol Oncol; 2019 Jul; 41(5):e336-e337. PubMed ID: 29889803
[TBL] [Abstract][Full Text] [Related]
32. Aggressive natural killer cell leukaemia: a rare and fatal disorder.
Gogia A; Kakar A; Byotra SP; Bhargav M
J Assoc Physicians India; 2010 Nov; 58():702-4. PubMed ID: 21510468
[TBL] [Abstract][Full Text] [Related]
33. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
Leahey AM; Bunin NJ; Belasco JB; Meek R; Scher C; Lange BJ
Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
[TBL] [Abstract][Full Text] [Related]
34. Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents.
Brody JP; Allen S; Schulman P; Sun T; Chan WC; Friedman HD; Teichberg S; Koduru P; Cone RW; Loughran TP
Cancer; 1995 May; 75(10):2474-83. PubMed ID: 7736391
[TBL] [Abstract][Full Text] [Related]
35. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
[TBL] [Abstract][Full Text] [Related]
36. [Epstein-Barr virus associated natural killer cell leukemia: report of an autopsy case].
Takai K; Sanada M; Shibuya H
Rinsho Ketsueki; 1995 May; 36(5):500-5. PubMed ID: 7783357
[TBL] [Abstract][Full Text] [Related]
37. A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletion.
Knudsen H; Grønbaek K; thor Straten P; Gisselø C; Johansen P; Timshel S; Bergmann OJ; Hansen NE; Ralfkiaer E
Br J Dermatol; 2002 Jan; 146(1):148-53. PubMed ID: 11841384
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic outcome of Epstein-Barr virus positive T/NK cell lymphoma in the upper aerodigestive tract.
Hahn JS; Lee ST; Min YH; Ko YW; Yang WI; Kim GE
Yonsei Med J; 2002 Apr; 43(2):175-82. PubMed ID: 11971211
[TBL] [Abstract][Full Text] [Related]
39. Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis.
Kwong YL; Lam CC; Chan TM
Br J Haematol; 2000 Jul; 110(1):197-202. PubMed ID: 10930998
[TBL] [Abstract][Full Text] [Related]
40. Natural killer cell lymphoma/leukemia: pathology and treatment.
Kwong YL; Chan AC; Liang RH
Hematol Oncol; 1997 May; 15(2):71-9. PubMed ID: 9375032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]